Insulintherapie bei der Katze – Tipps für die richtige Insulindosis

Das Management des Diabetes mellitus ist komplex und bedarf einer engen Zusammenarbeit zwischen Tierarzt und Tierbesitzer. Die Insulintherapie stellt die Grundlage der Diabetesbehandlung bei der Katze dar. Wenn möglich, sollte die Insulintherapie durch die Fütterung einer kohlenhydratarmen, proteinreichen Diät unterstützt werden.

• Literatur

• 1 Rudloff E. Diabetic ketoacidosis in the cat: Recognition and essential treatment. J Feline Med Surg 2017; 19 (11) 1167-1174
• 2 Sparkes AH, Cannon M, Church D. et al. ISFM consensus guidelines on the practical management of diabetes mellitus in cats. J Feline Med Surg 2015; 17 (03) 235-250
• 3 Behrend E, Holford A, Lathan P. et al. 2018 AAHA diabetes management guidelines for dogs and cats. J Am Anim Hosp Assoc 2018; 54 (01) 1-21
• 4 Roomp K, Rand J. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine. J Feline Med Surg 2009; 11 (08) 668-682
• 5 Roomp K, Rand J. Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control. J Feline Med Surg 2012; 14 (08) 566-572
• 6 Marshall RD, Rand JS, Morton JM. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins. J Feline Med Surg 2009; 11 (08) 683-691
• 7 Gostelow R, Scudder C, Hazuchova K. et al. One-year prospective randomized trial comparing efficacy of glargine and protamine zinc insulin in diabetic cats. 2017 ACVIM Forum Research Abstract Program. J Vet Intern Med 2017; 31 (04) 1273
• 8 Martin GJ, Rand JS. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy. J Feline Med Surg 2001; 3 (01) 23-30
• 9 Marshall RD, Rand JS, Morton JM. Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats. J Vet Pharmacol Ther 2018; 31 (03) 205-212
• 10 Marshall RD, Rand JS, Morton JM. Insulin glargine has a long duration of effect following administration either once daily or twice daily in divided doses in healthy cats. J Feline Med Surg 2008; 10 (05) 488-494
• 11 Gilor C, Ridge TK, Attermeier KJ. et al. Pharmacodynamics of insulin detemir and insulin glargine assessed by an isoglycemic clamp method in healthy cats. J Vet Intern Med 2010; 24: 870-874
• 12 Alt N, Kley S, Haessig M. et al. Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus. J Am Vet Med Assoc 2007; 230 (07) 1011-1017
• 13 Hazuchova K, Gostelow R, Scudder C. et al. Acceptance of home blood glucose monitoring by owners of recently diagnosed diabetic cats and impact on quality of life changes in cat and owner. J Feline Med Surg 2018; 20 (08) 711-720
• 14 Reusch C. Feline diabetes mellitus. In: Feldman EC, Nelson RW, Reusch C, Scott-Moncroie EB. eds. Canine and Feline Endocrinology. 4^th ed. St. Louis, Missouri: Elsevier; 2014: 258-314
• 15 Gostelow R, Hazuchova K, Scudder C. et al. Prospective evaluation of a protocol for transitioning porcine lente insulin-treated diabetic cats to human recombinant protamine zinc insulin. J Feline Med Surg 2017; 20 (02) 114-121
• 16 Zini E, Osto M, Franchini M. et al. Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia 2009; 52: 336-346
• 17 Gostelow R, Forcada Y, Graves T. et al. Systematic review of feline diabetic remission: separating fact from opinion. Vet J 2014; 202 (02) 208-221
• 18 Gostelow R. Uncovering the recipe for diabetic remission in the cat [PhD thesis]. Royal Veterinary College; 2016
• 19 Viebrock KA, Dennis J. Hypoglycemic episodes in cats with diabetes mellitus: 30 cases (2013–2015). J Feline Med Surg 2018; 20 (06) 563-570
• 20 Roomp K, Rand J. Rebound hyperglycaemia in diabetic cats. J Feline Med Surg 2016; 18 (08) 587-596
• 21 Zini E, Salesov E, Dupont P. et al. Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats. J Vet Intern Med 2018; 32 (03) 978-985
• 22 Hoenig M, Reusch C, Peterson ME. Beta cell and insulin antibodies in treated and untreated diabetic cats. Vet Immunol Immunopathol 2000; 77 (1 – 2): 93-102
• 23 Riederer A, Zini E, Salesov E. et al. Effect of the glucagon-like peptide-1 analogue exenatide extended release in cats with newly diagnosed diabetes mellitus. J Vet Intern Med 2016; 30 (01) 92-100
• 24 Nelson RW, Feldman EC, Ford SL. et al. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats. J Am Vet Med Assoc 1993; 203 (06) 821-827
• 25 Nelson R, Spann D, Elliott D. et al. Evaluation of the oral antihyperglycemic drug metformin in normal and diabetic cats. J Vet Intern Med 2004; 18 (01) 18-24